Early data from a University of Oxford study indicates the COVID-19 vaccine it jointly developed with AstraZeneca is effective against the P.1 variant, which originated in Brazil.  The study has not yet been published, but Reuters confirmed its results.  South Africa recently paused the vaccine rollout, where a similar variant is circulating after early study data indicated…